Oscar Vidal Gutiérrez

Oscar Vidal Gutiérrez (born 26 August 1960) is a Mexican medical doctor and researcher. He was born in Mexico City and completed his medical studies at the UANL Faculty of Medicine and "Dr. José Eleuterio González” University Hospital from the Autonomous University of Nuevo León.[1]

Oscar Vidal Gutiérrez
Born(1960-08-26)26 August 1960
NationalityMexican
Alma materAutonomous University of Nuevo León
Websitewww.droscarvidal.com

Vidal-Gutierrez is a specialist in gynecology and obstetrics and holds a Doctorate in Medicine from the UANL. He is also a postgraduate in Gynecological Oncology at the National Cancer Institute (INCAN). He also has a degree in law and a master's degree in Alternative Conflict Resolution Methods from the Faculty of Law and Criminology of the UANL.[2]

His area of oncological surgery and specialty is in pelvic, ovarian, endometrial, vulvar, and breast tumors. He is a member of the National System of Researchers (SNI), Level I, of CONAHCYT.[3]

He currently serves as the director of the UANL Faculty of Medicine.

Selected publications

edit
  • Clinical trial of radical hysterectomy by laparotomy vs. vaginally assisted laparoscopy in stage 1 cervical cancer. Doctorate thesis, Autonomous University of Nuevo León. 2001.[4]
  • Epidemiological algorithm for early detection of COVID-19 cases in Mexican Oncologic Center. Healthcare. 2022.[5]
  • Risk association of TOX3 gene polymorphisms with sporadic breast cancer in Mexican women. Current Oncology. 2022.[6]
  • Complete metabolic response after carboplatin desensitization in peritoneal carcinomatosis. Journal of Oncology Pharmacy Practice. 2022.[7]
  • Evaluation of ovarian reserve in women with Rheumatoid arthritis. Journal of family & Reproductive health. 2021.[8]
  • Nutritional screening in oncologic patients taking chemotherapy in a reference cancer center. Clinical Nutrition Espen. 2023.[9]

References

edit
  1. ^ "Óscar Vidal toma protesta como nuevo director de la Facultad de Medicina de la UANL". 15 December 2022.
  2. ^ "Líneas de investigación Oscar Vidal Gutiérrez".
  3. ^ "Trayectoria profesional Dr. Oscar Vidal Gutiérrez". 15 December 2022.
  4. ^ "Ensayo clínico de histerectomía radical por laparotomía vs. laparoscopía asistida por vía vaginal en cáncer de cervix estadio 1" (PDF).
  5. ^ González-Escamilla, M.; Pérez-Ibave, D. C.; Burciaga-Flores, C. H.; Ortiz-Murillo, V. N.; Ramírez-Correa, G. A.; Rodríguez-Niño, P.; Piñeiro-Retif, R.; Rodríguez-Gutiérrez, H. F.; Alcorta-Nuñez, F.; González-Guerrero, J. F.; Vidal-Gutiérrez, O.; Garza-Rodríguez, M. L. (2022). "Epidemiological Algorithm for Early Detection of COVID-19 Cases in a Mexican Oncologic Center Gutiérrez". Healthcare. 10 (3). doi:10.3390/healthcare10030462. PMC 8950794. PMID 35326940.
  6. ^ Solis-Coronado, Orlando; Villarreal-Vela, Mónica Patricia; Rodríguez-Gutiérrez, Hazyadee Frecia; González-Guerrero, Juan Francisco; Cerda-Flores, Ricardo M.; Alcorta-Núñez, Fernando; Camarillo-Cárdenas, Karen Paola; Pérez-Ibave, Diana Cristina; Vidal-Gutiérrez, Oscar; Ramírez-Correa, Genaro A.; Garza-Rodríguez, María Lourdes (2022). "Risk Association of TOX3 and MMP7 Gene Polymorphisms with Sporadic Breast Cancer in Mexican Women". Current Oncology. 29 (2): 1008–1017. doi:10.3390/curroncol29020086. PMC 8870835. PMID 35200585.
  7. ^ Villarreal-González, R. V.; González-Díaz, S. N.; Vidal-Gutiérrez, O.; Zayas-Villanueva, O. A.; Solís-Lara, H.; Santos-Fernández, W. J.; Casas-Murillo, C. A.; López-Méndez, A. (2022). "Complete metabolic response after carboplatin desensitization in Peritoneal Carcinomatosis". Journal of Oncology Pharmacy Practice. 28 (6): 1441–1445. doi:10.1177/10781552221074975. PMID 35119322.
  8. ^ Peña-Lizola, Sara Patricia; Sordia-Hernandez, Luis Humberto; Garcia-Luna, Selene Marysol; Valdes-Martinez, Otto; Skinner-Taylor, Cassandra Michele; Garza-Elizondo, Mario Alberto; Vidal-Gutierrez, Oscar; Villarreal-Perez, Jesus Zacarias; Eguia-Bernal, Miryam; Morales-Martinez, Felipe Arturo (2021). "Evaluation of Ovarian Reserve in Women With Rheumatoid Arthritis". Journal of Family & Reproductive Health. 15 (4): 236–241. doi:10.18502/jfrh.v15i4.7889. PMC 8897821. PMID 35340801.
  9. ^ "Nutritional screening in oncologic patients taking chemotherapy in a reference cancer center".
edit